General form of registration statement for all companies including face-amount certificate companies

SHAREHOLDERS' DEFICIT (Tables)

v3.24.2
SHAREHOLDERS' DEFICIT (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Equity [Abstract]    
Schedule of stock options activity

Options Outstanding

    

    

Weighted

    

Weighted

    

Average

Average

Number of

Exercise

Remaining

Aggregate

Shares Subject

Price Per

Contractual

Intrinsic Value

to Options

Share

Life (in years)

(in thousands)

Balance at December 31, 2022

 

2,724

$

2,332.80

 

2.8

 

  

Options granted

 

556

$

15.48

Options canceled

 

(1,256)

$

2,354.76

Balance at December 31, 2023

 

2,024

$

1,683.90

3.5

Options expired

(298)

$

2,808.00

Options canceled

 

(556)

$

15.48

Balance at March 31, 2024

 

1,170

$

2,189.70

 

2.0

 

$

Vested and exercisable at March 31, 2024

 

1,126

$

2,192.58

 

1.9

 

$

Options Outstanding

    

    

Weighted

    

Weighted

    

Average

Average

Number of

Exercise

Remaining

Aggregate

Shares Subject

Price Per

Contractual

Intrinsic Value

to Options

Share

Life (in years)

(in thousands)

Balance at December 31, 2021

 

3,345

$

2,001.60

 

3.60

 

  

Options granted

 

361

$

1,857.60

Options exercised

 

-2

$

1,814.40

Options canceled / expired

 

-980

$

903.60

Balance at December 31, 2022

 

2,724

$

2,332.80

2.8

Options granted

 

556

$

15.48

Options canceled / expired

 

-1,256

$

2,354.76

Balance at December 31, 2023

 

2,024

$

1,683.90

 

2.5

 

$

Vested and exercisable at December 31, 2023

 

1,498

$

2,041.20

 

2.0

 

$

Schedule of stock options outstanding and exercisable

Options Outstanding

Options Exercisable

    

Weighted

    

    

    

Average

Weighted

Weighted

Remaining

Average

Average

Number of

Contractual

Exercise Price

Number

Exercise Price

Outstanding

Life (in years)

Per Share

Exercisable

Per Share

138

 

0.5

$

2,304.00

 

138

$

2,304.00

546

1.8

$

1,908.00

546

$

1,908.00

83

2.0

$

2,016.00

72

$

2,016.00

319

2.5

$

2,754.00

309

$

2,754.00

83

2.9

$

1,857.60

61

$

1,857.60

1,170

 

2.0

$

2,189.70

 

1,126

$

2,192.58

Options Outstanding

Options Exercisable

    

Weighted

    

    

    

Average

Weighted

Weighted

Remaining

Average

Average

Number of

Contractual

Exercise Price

Number

Exercise Price

Outstanding

Life (in years)

Per Share

Exercisable

Per Share

298

 

0.1

$

2,808.00

 

298

$

2,808.00

138

 

0.8

$

2,304.00

 

138

$

2,304.00

546

2.1

$

1,908.00

493

$

1,908.00

83

2.3

$

2,016.00

72

$

2,016.00

319

2.8

$

2,754.00

262

$

2,754.00

83

3.2

$

1,857.60

50

$

1,857.60

556

4.5

$

15.48

185

$

15.48

2,024

 

2.5

$

1,683.90

 

1,498

$

2,041.20

Schedule of assumptions used to determine fair value of the awards  

    

Year Ended December 31, 

 

2023

    

2022

Expected life (in years)

 

5.0

 

5.0

Risk-free interest rate

 

4.0

%  

1.7

%

Dividend yield

 

%  

%

Expected volatility

 

137

%  

132

%

Schedule of warrants

    

Number of Warrants outstanding

Convertible debt, warrants issued

 

480

Debenture, warrants issued

764

Other warrants issued

500

December 2020 equity financing warrants issued

9,088

Total warrant outstanding

 

10,832

    

Number of Warrants outstanding

Balance at December 31, 2021

 

10,944

Debenture, warrants issued

500

Balance at December 31, 2022

 

11,444

Warrants expired

 

(613)

Warrants issued

41,667

Warrants exercised

(41,667)

Balance at December 31, 2023

 

10,832